Brice de la Crompe

Brice de la Crompe

Auto-generated profile, based on publicly available information

Brice de la Crompe

Université de Bordeaux, Institut des Maladies Neurodégénératives, 33076, Bordeaux, France

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Current Biology
Verified
Journal Article
Open access
AAAsier Aristieta
Asier Aristieta
MBMassimo Barresi
Massimo Barresi
SLShiva Azizpour Lindi
Shiva Azizpour Lindi
GBGrégory Barrière
Grégory Barrière
GCGilles Courtand
Gilles Courtand
NMNicolas Mallet
Nicolas Mallet
The basal ganglia (BG) inhibit movements through two independent circuits: the striatal neuron-indirect and the subthalamic nucleus-hyperdirect pathways. These pathways exert opposite effects onto external globus pallidus (GPe) neurons, whose functional importance as a relay has changed drastically with the discovery of two distinct cell types, namely the prototypic and the arkypallidal neurons. However, little is known about the synaptic connectivity scheme of different GPe neurons toward both motor-suppressing pathways, as well as how opposite changes in GPe neuronal activity relate to locomotion inhibition. Here, we optogenetically dissect the input organizations of prototypic and arkypallidal neurons and further define the circuit mechanism and behavioral outcome associated with activation of the indirect or hyperdirect pathways. This work reveals that arkypallidal neurons are part of a novel disynaptic feedback loop differentially recruited by the indirect or hyperdirect pathways and that broadcasts inhibitory control onto locomotion only when arkypallidal neurons increase their activity.

26 March 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
BCBrice de la Crompe
Brice de la Crompe
AAAsier Aristieta
Asier Aristieta
ALArthur Leblois
Arthur Leblois
SESalma Elsherbiny
Salma Elsherbiny
TBThomas Boraud
Thomas Boraud
NMNicolas Mallet
Nicolas Mallet
The dynamical properties of cortico-basal ganglia (CBG) circuits are dramatically altered following the loss of dopamine in Parkinson’s disease (PD). The neural circuit dysfunctions associated with PD include spike-rate alteration concomitant with excessive oscillatory spike-synchronization in the beta frequency range (12–30 Hz). Which neuronal circuits orchestrate and propagate these abnormal neural dynamics in CBG remains unknown. In this work, we combine in vivo electrophysiological recordings with advanced optogenetic manipulations in normal and 6-OHDA rats to shed light on the mechanistic principle underlying circuit dysfunction in PD. Our results show that abnormal neural dynamics present in a rat model of PD do not rely on cortical or subthalamic nucleus activity but critically dependent on globus pallidus (GP) integrity. Our findings highlight the pivotal role played by the GP which operates as a hub nucleus capable of orchestrating firing rate and synchronization changes across CBG circuits both in normal and pathological conditions.

1 March 2014 in Molecular Imaging
Verified
Journal Article
Open access
NANicolas & Neuropsychiatry Arlicot
Nicolas & Neuropsychiatry Arlicot
CTClaire Tronel
Claire Tronel
SBSylvie Bodard
Sylvie Bodard
LGLucette Garreau
Lucette Garreau
BCBrice de la Crompe
Brice de la Crompe
SCSylvie Chalon
Sylvie Chalon
Excitotoxicity leads to an inflammatory reaction involving an overexpression of: translocator protein 18 kDa (TSPO) in cerebral microglia and astrocytes. Therefore, we performed ex vivo explorations with [125]-CLINDE, a TSPO-specific radioligand, to follow the time course of TSPO expression, in parallel with lesion progression, over 90 days after induction of cerebral excitotoxicity in rats intrastriatally injected with quinolinic acid. Biodistribution data showed a significant increase in CLINDE uptake on the injured side from 1 days postlesion (dpl); the maximal striatal binding values evidenced a plateau between 7 and 30 dpl. [125I]-CLINDE binding was displaced from the lesion by PK11195, suggesting TSPO specificity. These results were confirmed by ex vivo autoradiography. Combined immunohistochemical studies showed a marked increase in microglial expression in the lesion, peaking at 14 dpl, and astrocytic reactivity enhanced at 7 and 14 dpl, whereas a prominent neuronal cell loss was observed. At 90 dpl, CLINDE binding and immunoreactivity targeting activated microglia, astrogliosis, and neuronal cell density returned to a basal level. These results show that both neuroinflammation and neuronal loss profiles occurred concomitantly and appeared to be transitory processes. These findings provide the possibility of a therapeutic temporal window to compare the differential effects of antiinflammatory treatments in slowing down neurodegeneration in this rodent model, with potential applications to humans.

1 March 2016 in Biological Psychiatry
Verified
Journal Article
Closed access
MBMatthieu F. Bastide
Matthieu F. Bastide
BCBrice de la Crompe
Brice de la Crompe
EDEvelyne Doudnikoff
Evelyne Doudnikoff
Pierre-Olivier FernagutPierre-Olivier Fernagut
Pierre-Olivier Fernagut
CGChristian E. Gross
Christian E. Gross
Erwan BezardErwan Bezard
Erwan Bezard

1 November 2020 in Journal of Neuroscience Methods
Verified
Journal Article
Open access
BCBrice De La Crompe
Brice De La Crompe
PCPhilippe Coulon
Philippe Coulon
IDIlka Diester
Ilka Diester
The vertebrate brain comprises a plethora of cell types connected by intertwined pathways. Optogenetics enriches the neuroscientific tool set for disentangling these neuronal circuits in a manner which exceeds the spatio-temporal precision of previously existing techniques. Technically, optogenetics can be divided in three types of optical and genetic combinations: (1) it is primarily understood as the manipulation of the activity of genetically modified cells (typically neurons) with light, i.e. optical actuators. (2) A second combination refers to visualizing the activity of genetically modified cells (again typically neurons), i.e. optical sensors. (3) A completely different interpretation of optogenetics refers to the light activated expression of a genetically induced construct. Here, we focus on the first two types of optogenetics, i.e. the optical actuators and sensors in an attempt to give an overview into the topic. We first cover methods to express opsins into neurons and introduce strategies of targeting specific neuronal populations in different animal species. We then summarize combinations of optogenetics with behavioral read out and neuronal imaging. Finally, we give an overview of the current state-of-the-art and an outlook on future perspectives.

16 April 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
BCBrice de la Crompe
Brice de la Crompe
AAAsier Aristieta
Asier Aristieta
ALArthur Leblois
Arthur Leblois
SESalma Elsherbiny
Salma Elsherbiny
TBThomas Boraud
Thomas Boraud
NMNicolas Mallet
Nicolas Mallet
An amendment to this paper has been published and can be accessed via a link at the top of the paper.